Micro Developing Active

百健收购Apellis Pharmaceuticals

评分
0.5
动能
▲ 0.0
文章
4
来源
2

摘要

如果一篇文章讨论了百健（Biogen）收购Apellis Pharmaceuticals或其对百健（Biogen）股票的影响，则该文章属于此叙述。

相关文章

Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?

Yahoo Finance · 四月 02, 2026
Mixed

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

Yahoo Finance · 四月 02, 2026
Mixed

来源

Apellis Pharmaceuticals (APLS) Hits 2-Year High on 140% Upside from … Yahoo Finance
Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late … Yahoo Finance
Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies … Yahoo Finance

时间线

最后更新 四月 01, 2026